drugset / Trial / NCT03921099
Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicty
RandomizedParallel-groupOpen-labelHealth-services research
Summary
A Randomized controlled trial aiming to investigate whether ascorbic acid has a role in preventing vancomycin induced nephrotoxicity or not in critically ill patients.
Timeline
- Start
- 2019-01-17
- Primary completion
- 2020-07
- Completion
- 2020-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 1 g | Oral |